Biostage, Inc. entered into securities purchase agreements with certain investors in a private placement an aggregate of 1,000,967 common shares at a price of $6 per share for the gross proceeds of $6.005802 million on March 31, 2023.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 USD | +3.02% | +3.02% | -52.10% |
1st Jan change | Capi. | |
---|---|---|
-52.10% | 34.21M | |
+7.15% | 220B | |
+6.60% | 183B | |
+9.86% | 133B | |
+24.32% | 107B | |
-0.95% | 63.05B | |
+11.04% | 51.74B | |
+4.81% | 50.47B | |
-1.43% | 40.91B | |
+24.40% | 31.91B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Biostage, Inc. announced that it expects to receive $6.005802 million in funding